ea0049gp124 | Endocrine Tumours | ECE2017
Tirosh Amit
, Shell Jasmine
, Green Patience
, Keutgen Xavier M.
, Sadowski Samira M.
, Lakis Mustapha el
, Nockel Pavel
, Patel Dhaval
, Nilubol Naris
, Kebebew Electron
Background: About 820% of patients with von Hippel-Lindau disease (vHLd) develop pancreatic neuroendocrine tumors (PNETs). However, prognostic markers for these tumors are lacking. The VHL gene mutation type is associated with the clinical phenotype of vHLd. Hence, we aimed to determine whether VHL mutation characteristics may be associated with PNETs phenotype in patients with vHLd.Methods: A prospective study of patients with vHLd and PNETs with ...